Celloram Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A
  • (Cancelled)

  • Investors
  • 5

Celloram General Information

Description

Developer of novel therapeutics designed for cancer, immune and metabolic disorders. The company develops various forms of cell therapy and small molecule therapeutics that harness the body's own unique potential to heal and battle chronic illnesses including cancer, autoimmune disease, chronic inflammatory, and metabolic disorders, enabling medical professionals to ignite their patient's body's self-healing process.

Contact Information

Website
www.celloram.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 11000 Cedar Avenue
  • 100th Floor Suite 23
  • Cleveland, OH 44106
  • United States
+1 (216)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 11000 Cedar Avenue
  • 100th Floor Suite 23
  • Cleveland, OH 44106
  • United States
+1 (216)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Celloram Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A) Cancelled Pre-Clinical Trials
4. Early Stage VC 01-Nov-2022 Completed Pre-Clinical Trials
3. Seed Round 01-Jan-2020 Completed Pre-Clinical Trials
2. Grant 31-Dec-2019 $220K $1M Completed Pre-Clinical Trials
1. Angel (individual) 01-Jan-2018 $1M $1M Completed Pre-Clinical Trials
To view Celloram’s complete valuation and funding history, request access »

Celloram Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Seed
To view Celloram’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Celloram Patents

  • 19

    Total Documents Applications and Grants

  • Total Patents Families

  • 2

    Granted

  • 13

    Pending

  • Expiring in next 12 mo

Celloram Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025262997-A1 Inhibitors of fatty acid binding proteins (fabps), methods of use and methods of making Pending 23-Apr-2024
US-20250325529-A1 Inhibitors of fatty acid binding proteins (fabps), methods of use and methods of making Pending 23-Apr-2024
WO-2025226670-A1 Inhibitors of fatty acid binding proteins (fabps), methods of use and methods of making Pending 23-Apr-2024
AU-2024284676-A1 Inhibitors of fatty acid binding proteins (fabps), methods of use and methods of making Pending 05-Jun-2023
EP-4719369-A2 Inhibitors of fatty acid binding proteins (fabps), methods of use and methods of making Pending 05-Jun-2023 C07D401/12
To view Celloram’s complete patent history, request access »

Celloram Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
VplatForm Venture Capital Minority
DAYLI Partners Venture Capital Minority
MedPacto Corporation Minority
Theragen Etex Holding Company Minority
United States Department of War Government
To view Celloram’s complete investors history, request access »

Ready to get started?

Request a free trial

Celloram FAQs

  • When was Celloram founded?

    Celloram was founded in 2018.

  • Where is Celloram headquartered?

    Celloram is headquartered in Cleveland, OH.

  • What industry is Celloram in?

    Celloram’s primary industry is Drug Discovery.

  • Is Celloram a private or public company?

    Celloram is a Private company.

  • What is Celloram’s current revenue?

    The current revenue for Celloram is .

  • How much funding has Celloram raised over time?

    Celloram has raised $9M.

  • Who are Celloram’s investors?

    VplatForm, DAYLI Partners, MedPacto, Theragen Etex, and United States Department of War have invested in Celloram.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process